Business news – Page 89
-
Business
Perrigo bags Elan and its bargain Irish tax rates
$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
-
Business
Thousands face job cuts after Valeant's Bausch buyout
Valeant plans to shed 10-15% of its workforce to save $800 million
-
Business
China corruption investigation broadens
GSK scandal is the trigger to clean up Chinese drug market
-
Business
Gas specialist branches out into carbon nanotubes
Linde group launches ink made with long, individual tubes
-
Feature
Phasing out fire retardants
With many brominated flame retardants facing bans, Nuala Moran examines the industry’s dash for new ones
-
Business
Lilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
PolyOne to close six sites and shed 250 jobs
Former Spartech manufacturing facilities are ‘redundant’ after takeover in March
-
Business
Monsanto abandons GM crops in Europe
Company will focus on conventional plant breeding in EU and biotech elsewhere
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
Business
Chemistry will underpin economic growth, say industry leaders
The UK chemical sector needs to rebuild supply chains and present a unified voice to government
-
Business
Texas plant explosion prompts calls for stricter rules
The incident was caused by unregulated and improper storage of ammonium nitrate, investigators find
-
-
Business
Evotec moves business back to UK
Pharma company closes operations in India, citing distance from customers
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe
-
Opinion
Target acquired
Knowing a drug’s exact biochemistry has never been a prerequisite for approval, says Derek Lowe, and nor should it be
-
Business
Sluggish recovery for European chemical sector
Industry body predicts second consecutive yearly drop in output with growth not expected to start again until 2014
-
Business
Aspen in $1 billion deal with Merck & Co
South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
Business
UK government to boost shale gas industry
Plans to invest in shale gas follow reports of vast reserves in the north of England